Sarah Cannon Research Institute: Tennessee Oncology, Nashville

1100 Charlotte Avenue
Nashville, Tennessee 37203

We've found

1 trials

at this facility

An Open-Label Study of Parsaclisib in Relapsed or Refractory Follicular Lymphoma (CITADEL-203)

Status: Enrolling, Phase II
Updated: 12/31/1969

from

Nashville, TN

Use our guide to learn which trials are right for you!